Hereditary polyposis syndromes and hereditary non-polyposis colorectal cancer

被引:36
作者
Allen, BA [1 ]
Terdiman, JP [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
adenomatous polyposis diagnosis/aetiology/genetics/therapy; intestinal polyps/diagnosis/genetics; non-polyposis/diagnosis/genetics/therapy; genetic predisposition to disease;
D O I
10.1016/S1521-6918(02)00149-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Colorectal cancer due to hereditary syndromes comprises approximately 5% of the overall colorectal cancer burden. Conditions fall into two distinct categories, the polyposis syndromes and hereditary non-polyposis colorectal cancer. It is important for the clinician to have a working knowledge of both as screening and surveillance recommendations differ significantly from those applicable to the general population. The polyposis syndromes include familial adenomatous polyposis, Peutz-Jeghers syndrome, juvenile polyposis, and Cowden syndrome. For each condition, a review of both the intestinal and extra-intestinal clinical findings is presented as well as the genetic basis, genetic testing, screening, surveillance and treatment options. As genetic testing for several of these conditions has recently become both commercially available and standard practice, special attention is given to indications and strategies for genetic testing in hereditary colorectal cancer syndromes.
引用
收藏
页码:237 / 258
页数:22
相关论文
共 104 条
  • [1] Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome
    Aarnio, M
    Mecklin, JP
    Aaltonen, LA
    NystromLahti, M
    Jarvinen, HJ
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (06) : 430 - 433
  • [2] Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC):: A prospective follow-up study
    Aktan-Collan, K
    Haukkala, A
    Mecklin, JP
    Uutela, A
    Kääriäinen, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (04) : 608 - 611
  • [3] ALBRECHT S, 1992, CANCER-AM CANCER SOC, V70, P869, DOI 10.1002/1097-0142(19920815)70:4<869::AID-CNCR2820700424>3.0.CO
  • [4] 2-E
  • [6] Ballhausen WG, 2000, ANN NY ACAD SCI, V910, P36
  • [7] Molecular and clinical characteristics of MSH6 variants:: An analysis of 25 index carriers of a germline variant
    Berends, MJW
    Wu, Y
    Sijmons, RH
    Mensink, RGJ
    van der Sluis, T
    Hordijk-Hos, JM
    de Vries, EGE
    Hollema, H
    Karrenbeld, A
    Buys, CHCM
    van der Zee, AGJ
    Hofstra, RMW
    Kleibeuker, JH
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (01) : 26 - 37
  • [8] Bertario L, 2001, INT J CANCER, V95, P102, DOI 10.1002/1097-0215(20010320)95:2<102::AID-IJC1018>3.0.CO
  • [9] 2-8
  • [10] Bertario L, 1999, INT J CANCER, V80, P183, DOI 10.1002/(SICI)1097-0215(19990118)80:2<183::AID-IJC4>3.0.CO